全文获取类型
收费全文 | 56241篇 |
免费 | 4526篇 |
国内免费 | 153篇 |
专业分类
耳鼻咽喉 | 511篇 |
儿科学 | 1508篇 |
妇产科学 | 1075篇 |
基础医学 | 7449篇 |
口腔科学 | 953篇 |
临床医学 | 6233篇 |
内科学 | 10772篇 |
皮肤病学 | 804篇 |
神经病学 | 4844篇 |
特种医学 | 2193篇 |
外科学 | 9373篇 |
综合类 | 782篇 |
一般理论 | 57篇 |
预防医学 | 5587篇 |
眼科学 | 1261篇 |
药学 | 4041篇 |
1篇 | |
中国医学 | 53篇 |
肿瘤学 | 3423篇 |
出版年
2023年 | 320篇 |
2022年 | 450篇 |
2021年 | 1154篇 |
2020年 | 654篇 |
2019年 | 1086篇 |
2018年 | 1305篇 |
2017年 | 951篇 |
2016年 | 1025篇 |
2015年 | 1228篇 |
2014年 | 1797篇 |
2013年 | 2491篇 |
2012年 | 3800篇 |
2011年 | 3888篇 |
2010年 | 2105篇 |
2009年 | 1868篇 |
2008年 | 3393篇 |
2007年 | 3639篇 |
2006年 | 3537篇 |
2005年 | 3436篇 |
2004年 | 3180篇 |
2003年 | 3026篇 |
2002年 | 2853篇 |
2001年 | 882篇 |
2000年 | 838篇 |
1999年 | 836篇 |
1998年 | 642篇 |
1997年 | 517篇 |
1996年 | 486篇 |
1995年 | 514篇 |
1994年 | 431篇 |
1993年 | 401篇 |
1992年 | 543篇 |
1991年 | 486篇 |
1990年 | 504篇 |
1989年 | 467篇 |
1988年 | 431篇 |
1987年 | 376篇 |
1986年 | 384篇 |
1985年 | 428篇 |
1984年 | 370篇 |
1983年 | 301篇 |
1982年 | 255篇 |
1981年 | 232篇 |
1980年 | 212篇 |
1979年 | 242篇 |
1978年 | 234篇 |
1974年 | 210篇 |
1973年 | 194篇 |
1972年 | 188篇 |
1968年 | 185篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
Georg Hahn Sharon M. Lutz Julian Hecker Dmitry Prokopenko Michael H. Cho Edwin K. Silverman Scott T. Weiss Christoph Lange 《Genetic epidemiology》2021,45(1):82-98
locStra is an ‐package for the analysis of regional and global population stratification in whole‐genome sequencing (WGS) studies, where regional stratification refers to the substructure defined by the loci in a particular region on the genome. Population substructure can be assessed based on the genetic covariance matrix, the genomic relationship matrix, and the unweighted/weighted genetic Jaccard similarity matrix. Using a sliding window approach, the regional similarity matrices are compared with the global ones, based on user‐defined window sizes and metrics, for example, the correlation between regional and global eigenvectors. An algorithm for the specification of the window size is provided. As the implementation fully exploits sparse matrix algebra and is written in C++, the analysis is highly efficient. Even on single cores, for realistic study sizes (several thousand subjects, several million rare variants per subject), the runtime for the genome‐wide computation of all regional similarity matrices does typically not exceed one hour, enabling an unprecedented investigation of regional stratification across the entire genome. The package is applied to three WGS studies, illustrating the varying patterns of regional substructure across the genome and its beneficial effects on association testing. 相似文献
993.
994.
995.
Romi Goldschlager Hedley Roth Jarryd Solomon Scott Robson Jessica Green Sarah Green Manfred Spanger Robyn Gunn Peter Cameron 《Emergency radiology》2014,21(4):367-372
Current literature suggests that a large proportion of chest X-rays (CXRs) performed in emergency department (ED) patients with chest pain and suspected acute coronary syndrome (ACS) are unnecessary. The Canadian ACS Guidelines aim to guide clinicians in the appropriate use of CXR within this patient population. This study determined the prevalence of clinically significant CXR abnormalities and assessed the utility of the guidelines in a population of ED patients with chest pain and suspected ACS. Included in the study were participants over the age of 18 who presented to an Australian metropolitan ED, over a 1-year period, with a primary complaint of chest pain and who had a CXR and troponin level ordered in the ED (N?=?760). We retrospectively compared their radiographic findings with their recommendations for CXR according to the ACS Guidelines. We found that 12 % of the participants had a clinically significant chest X-ray. The guidelines had a sensitivity of 80 % (95 % CI 0.70–0.87) and specificity of 50 % (95 % CI 0.47–0.54). The positive predictive value was 18 % (95 % CI 0.15–0.22) with a 95 % negative predictive value (95 % CI 0.92–0.97). Had the ACS guidelines been applied to our patient population, the number of CXR performed would have been reduced by 47 %. This study suggests that the ACS Guidelines has the potential to reduce the numbers of unnecessary CXR performed in ED patients. However, this would come at the expense of missing a minority of significant CXR abnormalities. 相似文献
996.
997.
Anthony H Chavez K Scott Coffield M Hasan Rajab Chanhee Jo 《Asian journal of andrology》2013,15(2):246-248
The purpose of this study was to determine the incidence rate of prostate cancer among men with erectile dysfunction (ED) treated with phosphodiesterase type 5 inhibitors (PDE-5i) over a 7-year period vs. men with ED of the same age and with similar risk factors who were not treated with PDE-5i. In a retrospective review of electronic medical records and billing databases between the years 2000 and 2006, men with ED between the ages of 50 and 69 years and no history of prostate cancer prior to 2000 were identified. These individuals were divided into two groups: 2362 men who had treatment with PDE-5i, and 2612 men who did not have treatment. Demographic data in each group were compared. During the study period, 97 (4.1%) men with ED treated with PDE-5i were diagnosed with prostate cancer compared with 258 (9.9%) men with ED in the non-treated group (P<00001). A higher percentage of African Americans were treated with PDE-5i vs. those who were not (10.5% vs. 7.1% P<0.0001). The PDE-5i group had lower documented diagnosis of elevated prostate-specific antigen (10.0% vs. 13.1% P=0.0008) and higher percentage of benign prostatic hyperplasia (38.4% vs. 35.1% P=0.0149). Men with ED treated with PDE-5i tended to have less chance (adjusted odds ratio: 0.4; 95% confidence intervals: 0.3–0.5; P<0.0001) of having prostate cancer. Our data suggest that men with ED treated with PDE-5i tended to have less of a chance of being diagnosed with prostate cancer. Further research is warranted. 相似文献
998.
Andrew M. Thompson Patrick D. OConnor Vanessa Yardley Louis Maes Delphine Launay Stephanie Braillard Eric Chatelain Baojie Wan Scott G. Franzblau Zhenkun Ma Christopher B. Cooper William A. Denny 《ACS medicinal chemistry letters》2021,12(2):275
Antitubercular 7-substituted 2-nitroimidazo[2,1-b][1,3]oxazines were previously shown to exhibit potent antileishmanial and antitrypanosomal activities, culminating in a new clinical investigational drug for visceral leishmaniasis (DNDI-0690). To offset development risks, we continued to seek further leads with divergent candidate profiles, especially analogues possessing greater aqueous solubility. Starting from an efficacious monoaryl derivative, replacement of the side chain ether linkage by novel amine, amide, and urea functionality was first explored; the former substitution was well-tolerated in vitro and in vivo but elicited marginal alterations to solubility (except through a less stable benzylamine), whereas the latter groups resulted in significant solubility improvements (up to 53-fold) but an antileishmanial potency reduction of at least 10-fold. Ultimately, we discovered that O-carbamate 66 offered a more optimal balance of increased solubility, suitable metabolic stability, excellent oral bioavailability (100%), and strong in vivo efficacy in a visceral leishmaniasis mouse model (97% parasite load reduction at 25 mg/kg). 相似文献
999.
1000.